Documente Academic
Documente Profesional
Documente Cultură
The syndrome of acute glomerulonephritis has been reported following many other bacterial illnesses
(eg,Streptococcus pneumoniae, Staphylococcus aureus and S epidermidis, Rickettsia rickettsiae,
Mycoplasmaspecies, Meningococcus species, Leptospira species). In addition, certain viral illnesses
have preceded the onset of fairly typical acute glomerulonephritis; among the most common are
varicella-zoster virus (VZV), cytomegalovirus (CMV), and the Epstein-Barr virus (EBV).
Additional evidence has also been presented to support the anti-immunoglobulin activity or glomerular
plasmin-binding activity of streptococcal antigens. The cross-reactivity of streptococci and mammalian
tissue implicating molecular mimicry in acute rheumatic fever led to evidence of a similar mechanism
involved in APSGN. However, the similar cross-reactivity patterns of rheumatogenic and nephritogenic
strains of streptococci argue against molecular mimicry involving M proteins.
Glomerular-bound streptococcal antibodies also serve as fixed antigens and bind to circulating
antistreptococcal antibodies, forming immune complexes. Complement fixation via the classic
pathway leads to the generation of additional inflammatory mediators and recruitment of inflammatory
cells.
Two major antigens have presently been identified as the potential cause(s) of APSGN: A zymogen
precursor of exotoxin B (SPEB [streptococcal pyrogenic toxin B]) or nephritis strainassociated
protein (NSAP), and nephritis-associated plasmin receptor (NAPlr), a glycolytic enzyme, which has
glyceraldehydes-3-phosphate dehydrogenase (GAPDH) activity[8, 9, 10, 11, 12]
NSAP is a 46- to 47-kd protein that is unique to the extracellular products of nephritogenic
streptococci. NSAP was demonstrated in glomerular deposits of 14 of 21 patients with APSGN, but
none in control biopsy samples from 5 patients with acute kidney injury and 11 with nonstreptococcal
glomerulonephritis. NSAP was also detected in serum from 96% of APSGN patients compared with
15-20% of patients with either acute kidney injury or impetigo. [13] NSAP has antigenic, biochemical, and
structural similarities to streptokinase from group C streptococcal organisms, binds to plasmin, and is
a plasminogen activator. However, streptokinase cannot be demonstrated in glomerular deposits for
patients with APSGN, and serum levels of purified group A streptokinase were similar in patients with
APSGN and those with acute kidney injury. Thus, although NSAP and streptokinase have similarities,
they appear to be 2 distinct proteins.[13]
Yoshizawa et all isolated a 43-kd protein called preabsorbing antigen (PA-Ag) that is putatively
identical to endostreptosin.[14, 15] PA-Ag has the ability to preabsorb the antibody in convalescent sera
from patients with APSGN and thus prevent its deposition in glomeruli. PA-Ag activates the alternative
pathway.[15] This 43-kd protein was later identified by Yamakami et al as NAPlr. [16] These researchers
noted that NAPlr was present in 100% of the early biopsy samples from in glomeruli of patients with
APSGN.[17] The glomerular distribution of NAPlr deposition and plasmin activity determined by in situ
zymography are identical.
The fact that NAPlr did not co-localize with C3 in glomerular deposits suggests that (1) complement
was activated by NAPlr in the circulation rather than in situ, and (2) NAPlr induced APSGN
independently of complement activation by binding to the glomerular basement membrane (GBM) and
mesangial matrix via its adhesive character, subsequently trapping and activating plasmin and
causing in situ glomerular damage by degrading the GBM or activating latent matrix metalloproteases.
[17, 18]
A proposed mechanism for acute poststreptococcal glomerulonephritis is that soluble, released NAPlr
binds to glomeruli and provide a mechanism to capture plasmin activated by streptokinase. The
activated plasmin bound to NAPlr associates with the GBM and mesangium. Both NAPlr and NSAP
are capable of inducing chemotactic (monocyte chemoattractant protein 1) and interleukin (IL)6
moieties in mesangial cells, promoting enhanced expression of adhesion molecules. Peripheral blood
leukocytes also release other cytokines such as tumor necrosis factor-alpha, IL-8, and transforming
growth factor-beta, which react with NSAP. These findings highlight the inflammatory potential of
these nephritogenic antigens.[19, 20, 21, 22]
Bound plasmin can cause tissue destruction by direct action on the glomerular basement membrane
or by indirect activation of procollagenases and other matrix metalloproteinases (MMPs). NAPlr can
also activate the alternate complement pathway, leading to accumulation of polymorphonuclear cells
and macrophages and local inflammation. In addition, the in situformed and circulating immune
complexes can readily pass through the altered glomerular basement membrane and accumulate on
the subepithelial space as humps.
Complement activation from both serum profiles and immunofluorescence patterns for glomerular
deposits indicates that C3 activation in APSGN is predominantly via the alternative pathway. [23, 24, 25] The
immune deposits consist of immunoglobulin G (IgG), C3, properdin, and C5. [25] These deposits rarely
contain C1q or C4, both components of the classic complement pathway. A recent study also showed
evidence for activation of the lectin-binding pathway from deposition of membrane-bound lipoprotein
in some patients with APSGN.[26]
During the early phase of the diseases (first 2 wk), evidence of classical pathway activation is seen,
as demonstrated by transient depression of serum C1q, C2, and/or C4 concentrations. [27, 28, 29] and the
presence of circulating C1-inhibitor-C1r-C1s complexes or C4d fragments. It is proposed that the
circulating immune complexes in the acute stage of the disease due to classic complement pathway
activation is distinct from that seen in the glomerular immune deposits. APSGN with typical findings on
histopathology may occur in patients with no evidence of complement activation, as manifested by
depression of serum C3 concentrations.[30, 31]
Serum IgG levels are elevated in about 44% of patients with APSGN. [32] Less than 50% of patients with
elevated serum IgG levels, however, have glomerular deposits of IgG. Elevated IgG levels were more
likely to be found in patients with antistreptolysin O titers of greater than or equal to 833 Todd units
(P < .001). However, elevated serum IgG concentrations do not correlate with severity of disease, age
of the patient, or serum albumin or C3 levels. It would appear that failure to form antibody to a
glomerular-bound protein produced by nephritogenicStreptococcus, is thought to be the origin of the
IgG in glomerular deposits, is in some way significantly associated with elevated serum levels of IgG
and antibody to streptolysin O.[32]
A role for delayed-type hypersensitivity has been implicated in the pathogenesis of this disease. Early
in the course of APSGN, resident endothelial and mesangial cells are predominantly proliferated, and
this is accompanied by infiltration with polymorphonuclear leukocytes and monocytes. Macrophages
are effector cells that cause resident cellular proliferation. The infiltration of macrophages in the
glomeruli is mediated by complement-induced chemotaxis and, most likely, by an antigen-specific
event related to delayed-type hypersensitivity mediated by helper/inducer T cells.
Streptococcal M proteins and pyrogenic exotoxins can act as superantigens. These cause a marked
expansion of T cells expressing specific T-cell receptor B-chain variable gene segments. Massive T-
cell activation occurs, with release of T-cellderived lymphokines such as IL-1 and IL-6.
Autologous IgG in APSGN becomes antigenic and elicits an anti-IgG rheumatoid factor response,
leading to formation of cryoglobulins. Cryoglobulins, rheumatoid factors, and other autoimmune
phenomena occur in APSGN and are thought to play a role in the pathogenesis of the disease
together with streptococcal superantigens.
prognosis
Clearly and specifically explain the nature of the disease, its course, and the eventual prognosis of the
condition to the child (if old enough to understand) and the parents and/or caregivers. They need to
understand that, although complete resolution is expected, a small possibility exists for persistent
disease, and that an even smaller possibility exists for progression. This information is necessary for
some patients to ensure that compliance with the follow-up program occurs.
Clearly outline a follow-up plan and discuss the plan with the family. Blood pressure measurements
and urine examinations for protein and blood constitute the basis of the follow-up plan. Perform
examinations at 4- to 6-week intervals for the first 6 months and at 3- to 6-month intervals thereafter,
until both hematuria and proteinuria have been absent and the blood pressure has been normal for 1
year. Documenting that the low C3 has returned to normal after 8-10 weeks may be usefu
Medikasi
Medication Summary
The need for medicines in acute poststreptococcal glomerulonephritis (ASPGN) is usually limited in
scope and in length. Administer antibiotics (penicillin or erythromycin) for 10 days to ensure
eradication of the streptococcus if the disease is believed to be acute poststreptococcal
glomerulonephritis and if risk of contamination is present. Some clinicians use this treatment only
when evidence suggests an active infection.
Antihypertensives are usually not necessary after the child leaves the hospital, although mild
hypertension may persist for as many as 6 weeks. The medications that can be used span the entire
range of antihypertensives, such as vasodilators (eg, hydralazine), calcium channel-blocking agents
(eg, long-acting nifedipine, amlodipine), or angiotensin-converting enzyme (ACE) inhibitors (eg,
enalapril).
Carefully monitor blood pressure (BP) for at least 1 week after the drug is discontinued to ensure that
rebound hypertension does not occur.
Diuretic agents (eg, furosemide) are rarely necessary after the first 2 days; hypertension persisting
beyond the first week may suggest a diagnosis other than acute glomerulonephritis.
Patofisiologi
GNA PS timbul setelah infeksi tertentu, terutama strain tertentuyaitu grup A streptokokus.
Daerah infeksi biasanya saluran napas atas,termasuk telinga tengah, atau kulit.
Glomerulonefritis pascastreptokokusdapat terjadi setelah radang tenggorok dan jarang
dilaporkan bersamaandengan demam rematik akut.
1,2
GNA PS berawal apabila host rentan yang terpapar kumanStreptokokus grup A strain
nefritogenik bereaksi untuk membentuk antibodi terhadap antigen yang menyerang. GNA PS
merupakan kelainankompleks imun, namun mekanisme interaksi antara antigen dan
antiboditidak diketahui. Kompleks imun yang mengandung antigen streptokokusini
mengendap pada glomerulus. Ukuran komplek streptokokus-imunoglobulin adalah 15 nm
(streptokokus 10 nm dan imunoglobulin 5nm). Sedangkan ukuran
pore
membrana basalis pada anak dan dewasaadalah 2-3 nm dan 4-4,5 nm. Oleh karena itu GNA PS
banyak terjadi padaanak-anak daripada dewasa.
1,3
Kompleks antigen-antibodi terbentuk dalam aliran darah danterkumpul dalam glomerulus.
Akibat hal ini akan terjadi inflamasi padaglomerulus dan akan mengaktifkan sistem
komplemen.
4
17GNA PS adalah suatu penyakit imunologik akibat reaksi antigen-antbodi yang terjadi
dalam sirkulasi atau
in situ
dalam glomerulus. Prosesinflamasi yang mengakibatkan terjadinya jejas renal dipicu oleh
3
:a.
Aktivitas plasminogen menjadi plasmin oleh streptokinaseyang kemudian diikuti
oleh aktivasi kaskade komplemen.b.
Manifestasi Klinis
AnamnesisAdanya riwayat infeksi streptokokus sebelumnya seperti faringitis,tonsilitis, atau
pioderma.Berikut merupakan beberapa keadaan yang didapatkan dari anamnese
1
:1.
Periode latena.
Terdapat periode laten antara infeksi streptokokus dengan onsetpertama kali muncul gejala.b.
Pada umumnya, periode laten selama 1-2 minggu setelah infeksitenggorok dan 3-6 minggu
setelah infeksi kulitc.
Onset gejala dan tanda yang timbul bersamaan dengan faringitisbiasanya merupakan
imunoglobulin A (IgA) nefropati daripadaGNA PS.2.
Urin gelap disebabkan hemolisis eritrosit yang telah masuk kemembran basalis glomerular
dan telah masuk ke sistem tubular.3.
Edema periorbitala.
Onset munculnya sembab pada wajah atau mata tiba-tiba. Biasanyatampak jelas saat psaat
bangun tidur dan bila pasien aktif akantampak pada sore hari.b.
Pada beberapa kasus edema generalisata dan kongesti sirkulasiseperti dispneu dapat timbul.c.
Edema merupakan akibat dari tereksresinya garam dan air.d.
Gejala nonspesifik a.
Yaitu gejala secara umum penyakit seperti malaise, lemah, dananoreksia, muncul pada 50%
pasien.
21b.
Gejala yang timbul adalah edema, hematuria, dan hipertensidengan atau tanpa klinis GNA
PS.b.
95% kasus klinis memiliki 2 manifestasi, dan 40% memiliki semuamanifestasi akut nefritik
sindrom2.
Edemaa.
Edema tampak pada 80-90% kasus dan 60% menjadi keluhan saatke dokter.b.
Terjadi penurunan aliran darah yang bermanifestasi sedikit eksresinatrium dan urin menjadi
terkonsentrasi. Adanya retensi natriumdan air ini menyebabkan terjadinya edema.3.
Hipertensia.
Hipertensi muncul dalam 60-80% kasus dan biasanya pada orangyang lebih besar.b.
Jika ada hipertensi menetap, hal tersebut merupakan petunjuk progresifitas ke arah lebih
kronis atau bukan merupakan GNA PS.d.
22g.
Oliguriaa.
Hematuriaa.
Disfungsi ventrikel kiri dengan atau tanpa hipertensi atau efusiperikardium dapat timbul pada
kongestif akut dan fasekonvalesen.b.
Penatalaksanaan
GNA-PS tipikal tidak memerlukan penatalaksanaan spesifik.Terapi antibiotik yang sesuai
merupakan indikasi bila infeksi tetap ada.Gangguan pada fungsi ginjal yang mengakibatkan
hipertensi memerlukanpenanganan yang lebih spesifik, pengurangan konsumsi natrium,pengobatan
dengan diuretik atau obat antihipertensi. Pada kasus beratyang telah terjadi kegagalan ginjal,
dapat dilakukan hemodialisa atauperitoneal dialisa. Kortikosteroid juga dapat diberikan untuk
mengurangiperjalanan infeksi.
4
Terapi Medis :Terapi simtomatis untuk mengontrol edema dan tekanan darah
5
1.
Pada fase akut batasi garam dan air, jika hipertensi dapat diberikandiuretik. Loop diuretik
meningkatkan output urin.2.
Untuk hipertensi yang tidak dapat dikontrol dengan diuretik. Biasanyacalsium channel
blocker. Pada hipertensi maligna pemberiannitroprusid atau parenteral agen.
263.
Prognosis
Hanya sedikit pasien dengan GNA yang memerlukan perawatan dirumah sakit. Dan sebagian
besar akan pulang dalam waktu 2-4 hari.Semakin ce[at tekanan darah berada dalam nilai
normal dan diuresis telahkembali, sebagian besar anak dapat dirawat jalan.
5
Sebagian besar pasien akan sembuh, tetapi 5% di antaranyamengalami perjalanan penyakit
yang memburuk dengan cepat denganpembentukan kresen pada epitel glomerulus. Diuresis
akan menjadinormal kembali pada hari ke 7-10 setelah awal penyakit, denganmenghilangnya
senbab dan secara bertahap tekanan darah menjadi normalkembali. Fungsi ginjal membaik
dalam 1 minggu dan menjadi normaldalam waktu 3-4 minggu. Komplemen serum menjadi
normal dalamwaktu 6-8 minggu. Tetapi kelainan sedimen urin akan tetap terlihat
selamberbulan-bulan bahkan bertahun-tahun pada sebagian besar pasien.
2
28
DAFTAR PUSTAKA
1.
28
DAFTAR PUSTAKA
1.
Lum GM.2005.Glomerulonephritis.In:Hematuria&GlomerularDisease.In:Kidney&Urinary tr
act.In:Hay WW,LevinMJ,etc.editors.Current Pediatric Diagnosis and
Treatment.NewYork:McGraw-Hill.p.7135.